EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vicplas International's enterprise value is S$84.8 Mil.
Vicplas International's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was S$10.5 Mil. Therefore, Vicplas International's EV-to-EBITDA for today is 8.09.
The historical rank and industry rank for Vicplas International's EV-to-EBITDA or its related term are showing as below:
SGX:569'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.28 Med: 5.95 Max: 38.42
Current: 8.09
During the past 13 years, the highest EV-to-EBITDA of Vicplas International was 38.42. The lowest was 1.28. And the median was 5.95.
SGX:569's EV-to-EBITDA is ranked better than 77.41% of 487
companies
in the Medical Devices & Instruments industry
Industry Median: 16.36
vs SGX:569: 8.09
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Vicplas International EV-to-EBITDA Historical Data
The historical data trend for Vicplas International's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vicplas International's EV-to-EBITDA
For the Medical Devices subindustry, Vicplas International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vicplas International's EV-to-EBITDA falls into.
Vicplas International's current Enterprise Value is S$84.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was S$10.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicplas International (SGX:569) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Vicplas International's PE Ratio for today is calculated as:
Vicplas International's share price for today is S$0.115.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was S$0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Vicplas International's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Vicplas International (SGX:569) Business Description
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:569 has been successfully added to your 